blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0796848

EP0796848 - Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.04.2004
Database last updated on 20.07.2024
Most recent event   Tooltip09.04.2004No opposition filed within time limitpublished on 26.05.2004  [2004/22]
Applicant(s)For all designated states
HOECHST AKTIENGESELLSCHAFT
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2003/23]
Former [1997/39]For all designated states
HOECHST AKTIENGESELLSCHAFT
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / Wagner, Adalbert, Dr.
Hans-Fischer-Strasse 4
86368 Gersthofen / DE
02 / Heitsch, Holger, Dr.
Castellumstrasse 52
55252 Mainz-Kastel / DE
03 / Nölkne, Gerhard, Dr.
Starkeradweg 15
65843 Sulzbach / DE
04 / Wirth, Klaus, Dr.
Robert-Schumann-Ring 104
65830 Kriftel / DE
05 / Bernard, Prof, -Dr.
Hölderlinstrase 62
65779 Kelkheim / DE
[1997/39]
Application number, filing date97103611.605.03.1997
[1997/39]
Priority number, dateDE199611078419.03.1996         Original published format: DE 19610784
[1997/39]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP0796848
Date:24.09.1997
Language:DE
[1997/39]
Type: B1 Patent specification 
No.:EP0796848
Date:04.06.2003
Language:DE
[2003/23]
Search report(s)(Supplementary) European search report - dispatched on:EP01.07.1997
ClassificationIPC:C07D215/26, A61K31/47
[1997/39]
CPC data not yet available
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/39]
Extension statesSI07.04.1997
TitleGerman:Fluoralkyl- und Fluoralkoxysubstituierte hetero-cyclische Bradykinin-Antagonisten[1997/39]
English:Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists[1997/39]
French:Bradykinine antagonistes hétérocycliques substituées par fluoralkyl ou par fluoralkoxy[1997/39]
Examination procedure24.03.1998Examination requested  [1998/21]
11.11.1999Despatch of a communication from the examining division (Time limit: M04)
16.03.2000Reply to a communication from the examining division
12.09.2000Despatch of a communication from the examining division (Time limit: M06)
26.04.2001Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
08.06.2001Reply to a communication from the examining division
27.08.2001Despatch of a communication from the examining division (Time limit: M04)
20.12.2001Reply to a communication from the examining division
18.02.2002Despatch of a communication from the examining division (Time limit: M04)
05.06.2002Reply to a communication from the examining division
06.11.2002Communication of intention to grant the patent
17.03.2003Fee for grant paid
17.03.2003Fee for publishing/printing paid
Opposition(s)05.03.2004No opposition filed within time limit [2004/22]
Request for further processing for:08.06.2001Request for further processing filed
08.06.2001Full payment received (date of receipt of payment)
Request granted
22.06.2001Decision despatched
Fees paidRenewal fee
31.03.1999Renewal fee patent year 03
31.03.2000Renewal fee patent year 04
02.04.2001Renewal fee patent year 05
02.04.2002Renewal fee patent year 06
31.03.2003Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DA]EP0622361  (FUJISAWA PHARMACEUTICAL CO [JP]) [DA] 1,5* claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.